| Elizabeth Turner Cancro, FNP | |
|
6800 Lucy Corr Blvd, Chesterfield, VA 23832-6657 | |
| (804) 318-8584 | |
| (804) 748-5054 |
| Full Name | Elizabeth Turner Cancro |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 6800 Lucy Corr Blvd, Chesterfield, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639348758 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 0001078916 (Virginia) | Secondary |
| 363L00000X | Nurse Practitioner | 0024078916 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Turner Cancro, FNP 6800 Lucy Corr Blvd, Chesterfield, VA 23832 Ph: (804) 318-8584 | Elizabeth Turner Cancro, FNP 6800 Lucy Corr Blvd, Chesterfield, VA 23832-6657 Ph: (804) 318-8584 |
News Archive
Four scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have been awarded more than $2.2 million from the National Institutes of Health (NIH) to research the effects of nicotine and develop new tobacco-related drug therapies.
Being bullied in childhood has been associated with increased risk for anxiety, depression and even eating disorders. But according to new research, it's not only the victims who could be at risk psychologically, but also the bullies themselves.
The world will experience a significant acceleration in the speed of population aging over the coming years but slow down by mid-century, according to a study by Warren Sanderson, Professor and Co-Chairman of the Department of Economics, Stony Brook University; and colleagues from the World Population Program at the International Institute for Applied Systems Analysis in Austria.
Adaptimmune Therapeutics plc, a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced that it has initiated a Phase I/II study of its affinity enhanced T-cell therapy targeting the MAGE-A10 cancer antigen in patients with locally advanced or metastatic (Stage IIIb or IV) non-small cell lung cancer (NSCLC), the most prevalent type of lung cancer representing approximately 85 percent of lung cancers.
Animals must make predictions about future rewards when making decisions during daily life. Specific reward-related patterns of neuronal activity are known to underlie such decisions.
› Verified 6 days ago
Golda Trompeta, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7931 Mill River Ln, Chesterfield, VA 23832 Phone: 804-519-2823 | |
Hannah Braxton, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5625 Burnage Ct, Chesterfield, VA 23832 Phone: 804-878-3518 | |
Mrs. Laura Joyce Jensen, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6800 Lucy Corr Ct, Chesterfield, VA 23832 Phone: 804-318-8584 Fax: 804-748-5054 | |
Elethia Moore, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6801 Lucy Corr Ct, Chesterfield, VA 23832 Phone: 804-768-7318 | |
Patricia Hardy Lavinus, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 11102 Rabbit Ridge Rd, Chesterfield, VA 23838 Phone: 804-387-5820 | |
Germaine Kelley-pope, MSN APRN PMHNP-BC Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 9844 Lori Rd Ste 101, Chesterfield, VA 23832 Phone: 804-615-5118 Fax: 804-207-8831 | |
Portia Thelwell, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6800 Lucy Corr Boulevard, Chesterfield, VA 23832 Phone: 804-318-8584 |